Jerry Buttimer (Fine Gael) | Oireachtas source

-----affordability and risk-sharing in relation to the cost of the drug. The Minister for Health is engaging on this very sensitive matter. The cost of high-tech drugs is an issue about which we need to have a conversation but it is not one on which we should be pitting people against each other. I am happy to engage further with Senator Ardagh on the issue. Professor Michael Barry of the National Centre for Pharmacoeconomics has made his views on this matter very clear. It is important that Vertex reconsiders its position-----